Mukhtarova, Liliya A.,
Fedorova, Yulia Yu.,
Karunas, Aleksandra S.,
Prokofyeva, Darya S.,
Nurgalieva, Alfia Kh.,
Khusnutdinova, Elza K.,
Zagidullin, Shamil Z. (2023) bronchial asthma (BA), of which 1 million have a
severe form of the disease that is difficult to control
of fatal stroke was associated with the patient being in a generally
severe condition and a number of other
Savelieva, O.N.,
Karunas, A.S.,
Vlasova, A.O.,
Ahmetshin, A.A.,
Khidiyatova, I.M.,
Khusnutdinova, E.K. (2024) revealed a higher frequency of full methylation (100%) of the studied region in patients with
severeTyurin, A.V.,
Salimgareeva, M.K.,
Miniakhmetov, I.R.,
Khusainova, R.I.,
Samorodov, A.,
Pavlov, V.N.,
Kzhyshkowska, J. (2022) The immune system is
severely compromised in patients with COVID-19. The representative group of 43
statistical data,
severe COVID-19 with immune-system hyperactivity is observed mainly in elderly people
. This effect is implemented in
several ways: a direct effect of the virus on the promoter regions
Mukhametov, Ural,
Lyulin, Sergey,
Borzunov, Dmitry,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Sufianov, Albert (2023) . The purpose of this study is to examine the parameters of immunity in patients with
severe polytrauma
-substituted thietane-1,1-dioxide derivative (N-199/1) exhibiting antidepressant properties, in
several tests
of the trials were conducted in
several economically prosperous countries. The earliest initiated trials dates
Gilyazova, I.,
Timasheva, Ya.,
Karunas, A.,
Kazantseva, A.,
Sufianov, A.,
Mashkin, A.,
Korytina, G.,
Wang, Ya.,
Gareev, I.,
Khusnutdinova, E. (2023) The novel coronavirus infection (COVID-19) causes a
severe acute illness with the development